Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.02
+0.05 (1.01%)
At close: Sep 5, 2025, 4:00 PM
5.02
0.00 (0.00%)
After-hours: Sep 5, 2025, 5:34 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $271.07 million as of September 5, 2025. Its market cap has decreased by -31.04% in one year.
Market Cap
271.07M
Enterprise Value
147.09M
1-Year Change
-31.04%
Ranking
Category
Stock Price
$5.02
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $271.07M, a decrease of -0.11%. That is a compound annual growth rate of -0.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 268.37M | 23.30% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.80B |